IMMUNE-RELATED ADVERSE EVENTS
Clinical trials for IMMUNE-RELATED ADVERSE EVENTS explained in plain language.
Never miss a new study
Get alerted when new IMMUNE-RELATED ADVERSE EVENTS trials appear
Sign up with your email to follow new studies for IMMUNE-RELATED ADVERSE EVENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a single rituximab infusion tame Immunotherapy's harsh side effects?
Disease control Not yet recruitingThis trial investigates whether a single ultra-low dose of rituximab can safely manage immune-related side effects caused by checkpoint inhibitor therapy in people with malignant melanoma. Participants receive one 100 mg infusion of rituximab along with a steroid tapering plan an…
Matched conditions: IMMUNE-RELATED ADVERSE EVENTS
Phase: PHASE1 • Sponsor: Inge Marie Svane • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can we predict dangerous side effects of immunotherapy?
Knowledge-focused Not yet recruitingThis study aims to find biological markers that can predict immune-related side effects in cancer patients receiving immune checkpoint inhibitor therapy. Researchers will collect data from 440 participants to build a model that forecasts these adverse events. The goal is to impro…
Matched conditions: IMMUNE-RELATED ADVERSE EVENTS
Sponsor: Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC